Skip to Main Content

Paper Details

Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.
Lupus Sci Med
8
2022
Author NameAffiliation
Paul J NietertMedical University of South Carolina
  • 1 - 1

Datasets

Release 1.2